Kartik Balachandran, professor of biomedical engineering, will discuss how metrics derived via multiphoton microscopy correlate with early progression of calcific aortic valve disease at 12:55 p.m. Wednesday.
Old West: “Investment in Rafael Holdings (RFL) Represents an Extremely Asymmetric Opportunity”
Old West Investment Management, an investment management firm, published its first quarter 2021 investor letter – a copy of which can be downloaded here. An average return of 25% was delivered by the fund for the Q1 of 2021, ahead of its S&P 500 benchmark that delivered a 6% return for the same period. You can view the fund’s top 5 holdings to have a peek at their top bets for 2021.
Old West Investment Management, in their Q1 2021 investor letter, mentioned Rafael Holdings, Inc. (NYSE: RFL), and shared their insights on the company. Rafael Holdings, Inc. is a Newark, New Jersey-based clinical-stage oncology pharmaceutical company that currently has a $682.7 million market capitalization. Since the beginning of the year, RFL delivered an impressive 76.72% return, extending its 12-month gains to 192.06%. As of April 28, 2021, the stock closed at $41.38 per share.